Tech Company Financing Transactions

Pulmatrix Funding Round

5AM Ventures, Arch Venture Partners and Novartis BioVenture Fund participated in a $14 million Series B venture round for Pulmatrix. The round was announced on 8/15/2011.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

99 Hayden Ave. 390
Lexington, MA 02421
USA

Phone

(781) 357-2333

Website

www.pulmatrix.com

Email Address

[email protected]

Overview

Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ted Raad

        

Browse more venture capital transactions:

Prev: 8/15/2011: LendKey venture capital transaction
Next: 8/15/2011: Buddy Media venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary